The company's financial performance is poor due to significant deterioration in growth and profitability. Sales growth has turned negative, with a TTM decline of -17%. While annual profit growth for March 2016 was strong at 62%, this appears anomalous, as recent quarterly performance shows a profit decline of -33.21%, indicating high volatility and an unstable earnings base. Operating Profit Margins (OPM) have been on a consistent downward trend, falling from over 14% in 2015 to just 5% in the most recent quarter (Sep 2016). This compression suggests a loss of pricing power or an inability to control costs. Furthermore, a substantial and increasing portion of pre-tax profit is derived from 'Other Income' (33.3% in TTM), which indicates potential weakness in the core business operations.

Capital efficiency and returns are poor, showing a sharp and concerning decline across key metrics. The Return on Capital Employed (ROCE) has fallen from 20% in March 2016 to a current level of 12.97%. Similarly, Return on Equity (ROE) has collapsed from 24% to 10.06% over the same period, indicating that shareholder funds are generating significantly lower returns. The Asset Turnover ratio, a measure of how effectively assets are used to generate sales, halved from 1.95 in March 2015 to 1.02 in March 2016, highlighting a major drop in operational efficiency. The most alarming indicator is the Cash Conversion Cycle (CCC), which skyrocketed from 43 days to 123 days between March 2015 and March 2016. This tripling of the CCC signifies severe issues in managing working capital.

The company's financial health and prudence are rated as good. Management has maintained a conservative approach to leverage, as evidenced by a low and manageable debt-to-equity ratio, which stood at 0.13 in March 2016. This indicates that the company is not overly reliant on borrowed funds to finance its assets. The ability to service its debt is also very strong. The Interest Coverage Ratio has remained robust, standing at 12x on a TTM basis, meaning operating profits can cover interest expenses twelve times over, providing a significant safety margin. Furthermore, the company has a track record of sharing profits with shareholders, with dividend payout ratios of 30% and 24% in March 2015 and March 2016, respectively. This combination of low debt, strong debt servicing capacity, and consistent dividend payments reflects a prudent financial management approach.

The shareholding structure presents a mixed picture and is rated as average. A significant strength is the high and stable promoter holding, which has remained around 58% for several years. This high level of ownership demonstrates strong promoter conviction and aligns their interests with those of other shareholders. However, a notable weakness is the extremely low level of institutional investment. As of March 2024, Foreign Institutional Investors (FIIs) held only 0.48% and Domestic Institutional Investors (DIIs) held 0.56%. While DII holding has shown a slight upward trend, the combined institutional stake of just over 1% is very low. This suggests a lack of significant interest from professional fund managers and large institutions.

The company's accounting quality is rated as poor. The most significant red flag is the divergence between reported profits and cash generation. In the fiscal year ending March 2016, Apcotex reported a Net Profit of ₹39 crore, yet its Cash from Operating Activity was negative at -₹18 crore. This indicates that the profits declared on the income statement did not translate into cash inflows for the business. The CFO/Operating Profit ratio of -27% for the year starkly highlights this issue. Another concern is the high contribution of 'Other Income' to profitability. In the TTM period, Other Income of ₹11 crore constituted 33% of the Profit Before Tax of ₹33 crore. This heavy reliance on non-operational income to bolster profits suggests weakness in the core business and reduces the quality of earnings.